The U.S. Food and Drug Administration (FDA) has approved pharmaceutical company Bristol Myers Squibb’s (BMY) new schizophrenia drug called “Cobenfy.” The medication is the first new treatment for the ...
Equities in Canada’s largest centre closed out the week on a negative footing, though stocks did finish the week in the green. The TSX Composite Index fell 77.01 points to close Friday at 23,956.82.